Pramipexole EP Impurity B

Pramipexole EP Impurity B is a synthetic byproduct arising from the alkylation step in the Pramipexole synthesis pathway. It retains the piperazine core but features an un cyclized thiazole moiety, replacing the parent drug’s fused thiadiazole ring. The compound exhibits a branched alkyl chain substitution at the 4-position of the piperazine nitrogen, introducing steric hindrance that inhibits ring closure. This structural deviation creates a distinct chromatographic profile, enabling its identification as a critical process-related impurity. It serves as an HPLC reference standard for quantifying process consistency in Pramipexole API manufacturing.